Compare GoPro Inc (GPRO) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GoPro Inc vs Halozyme Therapeutics Inc. Common Stock — how do they compare? GoPro Inc trades at $1.19 (market cap $243.50M), while Halozyme Therapeutics Inc. Common Stock trades at $112.3 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 51.7× GoPro Inc's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, GoPro Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold GoPro Inc for 45 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.
| GPRO | HALO | |
|---|---|---|
Market Cap | $243.50M | $12.58B |
Volume | 11,527,160 | 2,179,278 |
Sector | Technology | Health |
52-Week High | $2.35 | $115.22 |
52-Week Low | $0.58 | $61.63 |
Typical Hold Time | 45 Days | 0 Days |
Enterprise Value | $302.28M | $14.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GoPro (GPRO) trades at $1.20, down 1.64% with a volatile trading pattern following recent merger announcements. The stock shows bullish technical signals despite negative fundamental metrics including a -28.52% net income margin and -497.15% ROE. Recent developments include a $285 million merger agreement with Starman Optical and significant retail investor interest from influencer Markiplier's 8.5% stake acquisition.
The proposed merger at $1.14 per share creates a potential exit opportunity, though current trading above this level suggests market optimism about deal terms. However, persistent negative cash flows, declining revenues, and shareholder litigation regarding deal fairness present substantial risks. The company's pivot into AI data centers offers growth potential but execution uncertainty remains high.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About GoPro Inc
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
Read more on GPRO →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
